BNP Paribas Asset Management’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $53.4M | Buy |
1,350,879
+154,487
| +13% | +$6.1M | 0.13% | 160 |
|
|
2025
Q1 | $36.1M | Buy |
1,196,392
+116,051
| +11% | +$3.5M | 0.1% | 216 |
|
|
2024
Q4 | $37.8M | Buy |
1,080,341
+300,620
| +39% | +$10.5M | 0.09% | 228 |
|
|
2024
Q3 | $31.2M | Sell |
779,721
-1,032
| -0.1% | -$41.3K | 0.08% | 242 |
|
|
2024
Q2 | $37.2M | Buy |
780,753
+2,160
| +0.3% | +$103K | 0.1% | 215 |
|
|
2024
Q1 | $33.8M | Buy |
778,593
+438,926
| +129% | +$19M | 0.09% | 235 |
|
|
2023
Q4 | $17.2M | Buy |
+339,667
| New | +$17.2M | 0.05% | 322 |
|
|
2019
Q4 | – | Sell |
-3,593
| Closed | -$215K | – | 843 |
|
|
2019
Q3 | $215K | Hold |
3,593
| – | – | ﹤0.01% | 827 |
|
|
2019
Q2 | $231K | Buy |
+3,593
| New | +$231K | ﹤0.01% | 867 |
|
|
2015
Q1 | – | Sell |
-3,692
| Closed | -$228K | – | 1060 |
|
|
2014
Q4 | $228K | Buy |
+3,692
| New | +$228K | ﹤0.01% | 932 |
|